SCHEMBL9871423

SCHEMBL9871423

CCCCc1nc(Cl)c(CO)n1Cc1ccc(NC(=O)C(CC#N)NC(=O)O)cc1

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ AGTR1 P30556 1/20 0.53
▸ AGTR2 P50052 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9767564 1.00 AGTR1 (0.53) AGTR1AGTR2
SCHEMBL9767781 0.87 — —
SCHEMBL9869151 0.87 — —
SCHEMBL9588531 0.82 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL9767515 0.81 AGTR1 (0.55) AGTR1AGTR2
SCHEMBL9767531 0.81 AGTR1 (0.55) AGTR1AGTR2
SCHEMBL9767507 0.78 AGTR2 (0.62) AGTR1AGTR2
SCHEMBL9767511 0.78 AGTR2 (0.62) AGTR1AGTR2
SCHEMBL9767419 0.78 AGTR1 (0.54) AGTR1AGTR2
SCHEMBL9767427 0.78 AGTR1 (0.54) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5041552-A Treatment of hypertension, heart failure, glaucoma and hyperaldosteronism WARNER-LAMBERT COMPANY (US) 1991-08-20 — — US disclosed
Send feedback